01 1Eli Lilly Kinsale Limited
02 3Eli Lilly and Company
03 3Synergy Health AST, LLC
01 6Olanzapine pamoate
02 1Olanzapine pamoate monohydrate
01 7U.S.A
NDC Package Code : 0002-1606
Start Marketing Date : 2009-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 0002-2003
Start Marketing Date : 2009-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (300mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 0002-2344
Start Marketing Date : 2009-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (405mg/2.7mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 63419-0509
Start Marketing Date : 2007-12-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71161-142
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-143
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (300mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-144
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (405mg/2.7mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Olanzapine Pamoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olanzapine Pamoate, including repackagers and relabelers. The FDA regulates Olanzapine Pamoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olanzapine Pamoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olanzapine Pamoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olanzapine Pamoate supplier is an individual or a company that provides Olanzapine Pamoate active pharmaceutical ingredient (API) or Olanzapine Pamoate finished formulations upon request. The Olanzapine Pamoate suppliers may include Olanzapine Pamoate API manufacturers, exporters, distributors and traders.
click here to find a list of Olanzapine Pamoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olanzapine Pamoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olanzapine Pamoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olanzapine Pamoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olanzapine Pamoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olanzapine Pamoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olanzapine Pamoate suppliers with NDC on PharmaCompass.
We have 2 companies offering Olanzapine Pamoate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
